Local News
Local News

Fulton Schools hosting Title I meeting on the northside Thursday

By
June 2, 2015

On Thursday, Fulton County Schools will host its second informational meeting of the week for parents to discuss the Comprehensive LEA Improvement Plan (CLIP) for all Title I Schools, District Parent Involvement Statement and Flexible Learning Program.

Thursday’s meeting is targeted for North Fulton families, although everyone is invited. A similar meeting was held in South Fulton on Tuesday.

The 6 p.m. meeting will be held on Thursday at Holcomb Bridge Middle School, 2700 Holcomb Bridge Road, Alpharetta.

For more information, call the Title I Department at 470-254-0200.

About the Author

Ernie Suggs is an enterprise reporter covering race and culture for the AJC since 1997. A 1990 graduate of N.C. Central University and a 2009 Harvard University Nieman Fellow, he is also the former vice president of the National Association of Black Journalists. His obsession with Prince, Spike Lee movies, Hamilton and the New York Yankees is odd.

Follow Ernie Suggs on facebookFollow Ernie Suggs on twitter
More Stories

The Latest

Jeffrey Briney was convicted of rape in two sexual assault cases that took place in 1986 in DeKalb County. (Dreamstime/TNS)

Credit: TNS

DNA leads to conviction of man in decades-old DeKalb sexual assaults

Student injured in lab explosion at Georgia Tech

Ex-Georgia poll worker to serve 20 months for threatening to bomb precinct

Featured

(Photo Illustration: Philip Robibero / AJC | Source: File, Pexels)

Credit: Philip Robibero / AJC

EXCLUSIVE

Amid federal pressure, Atlanta forced to evaluate vaunted contract diversity goals

The prospect of losing programs that require certain minority and women-owned business participation is "one of the most consequential moments in our history," the mayor said.

Time is running out to cash in on federal EV, clean energy tax credits

The clock is ticking for Georgians to use federal EV and clean energy tax credits to save money on a range of projects.

A rare disease exhausted him. A drug gives him energy to fight for others.

An FDA review of a drug for Barth syndrome shines a spotlight on how the agency weighs experimental treatments for rare diseases, which affect almost 30 million Americans.